NCT00877656View on ClinicalTrials.gov

HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

December 31, 2008

Conditions
T Cell Lymphoma
Interventions
BIOLOGICAL

HuMax-CD4

Active treatment

Sponsors
All Listed Sponsors
lead

Emergent BioSolutions

INDUSTRY